S P Hunger
Overview
Explore the profile of S P Hunger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1581
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DelRocco N, Loh M, Borowitz M, Gupta S, Rabin K, Zweidler-McKay P, et al.
Leukemia
. 2024 Feb;
38(4):720-728.
PMID: 38360863
Current strategies to treat pediatric acute lymphoblastic leukemia rely on risk stratification algorithms using categorical data. We investigated whether using continuous variables assigned different weights would improve risk stratification. We...
2.
Karol S, Larsen E, Cheng C, Cao X, Yang W, Ramsey L, et al.
Leukemia
. 2017 Jan;
31(6):1325-1332.
PMID: 28096535
The causes of individual relapses in children with acute lymphoblastic leukemia (ALL) remain incompletely understood. We evaluated the contribution of germline genetic factors to relapse in 2225 children treated on...
3.
Liu Y, Fernandez C, Smith C, Yang W, Cheng C, Panetta J, et al.
Clin Pharmacol Ther
. 2017 Jan;
102(1):131-140.
PMID: 28090653
Remission induction therapy for acute lymphoblastic leukemia (ALL) includes medications that may cause hepatotoxicity, including asparaginase. We used a genome-wide association study to identify loci associated with elevated alanine transaminase...
4.
Matlawska-Wasowska K, Kang H, Devidas M, Wen J, Harvey R, Nickl C, et al.
Leukemia
. 2016 Mar;
30(9):1909-12.
PMID: 26952838
No abstract available.
5.
Kolenova A, Kaiserova E, Makohusova M, Subova Z, Bubanska E, Oravkinova I, et al.
Neoplasma
. 2015 Aug;
62(5):812-20.
PMID: 26278138
Our aim was to analyze event-free (EFS) and overall survival (OS) among children and adolescents with acute lymphoblastic leukemia (ALL) treated with International BFM Intercontinental trial (ALL IC 2002) therapy...
6.
Schultz K, Carroll A, Heerema N, Bowman W, Aledo A, Slayton W, et al.
Leukemia
. 2014 Jan;
28(7):1467-71.
PMID: 24441288
We previously reported preliminary findings that post induction imatinib mesylate (340 mg/m(2)/day), in combination with intensive chemotherapy, resulted in outcomes similar to blood and marrow transplant (BMT) for pediatric patients...
7.
Schultz K, Devidas M, Bowman W, Aledo A, Slayton W, Sather H, et al.
Leukemia
. 2014 Jan;
28(4):964-7.
PMID: 24434862
No abstract available.
8.
Harrison C, Moorman A, Schwab C, Carroll A, Raetz E, Devidas M, et al.
Leukemia
. 2013 Oct;
28(5):1015-21.
PMID: 24166298
Intrachromosomal amplification of chromosome 21 (iAMP21) defines a distinct cytogenetic subgroup of childhood B-cell precursor acute lymphoblastic leukaemia (BCP-ALL). To date, fluorescence in situ hybridisation (FISH), with probes specific for...
9.
de Lorenzo P, Moorman A, Pieters R, Dreyer Z, Heerema N, Carroll A, et al.
Leukemia
. 2013 Sep;
28(2):428-30.
PMID: 24072099
No abstract available.
10.
Mangum D, Downie J, Mason C, Jahromi M, Joshi D, Rodic V, et al.
Leukemia
. 2013 Jul;
28(1):216-20.
PMID: 23881307
No abstract available.